SCHEMBL7096492

SCHEMBL7096492

c1cncc(NN2CCCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
CHRNA4 P43681 1/20 0.44
ALDH1A1 P00352 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 2/20 0.42
ADRA2A P08913 2/20 0.41
ADRA2B P18089 2/20 0.41
ADRA2C P18825 2/20 0.41
NPC1 O15118 1/20 0.41
PKM P14618 1/20 0.41
RAB9A P51151 1/20 0.41
CFTR P13569 1/20 0.41
GOPC Q9HD26 1/20 0.41
MAPT P10636 2/20 0.40
NAMPT P43490 1/20 0.40
USP2 O75604 1/20 0.40
MAPK1 P28482 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7098715 0.98 LMNA (0.44) CHRNB2CHRNA4ALDH1A1MEN1KMT2A
SCHEMBL6352342 0.98 LMNA (0.44) CHRNB2CHRNA4ALDH1A1MEN1KMT2A
SCHEMBL7141364 0.84 CHRNB2 (0.47) CHRNB2CHRNA4ALDH1A1KMT2AADRA2A
SCHEMBL2478525 0.84 SMN1; SMN2 (0.45) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL7485738 0.80 MAPT (0.51) ALDH1A1MEN1KMT2ALMNANPC1
SCHEMBL1837106 0.75 CHKA (0.46) MAPK1TDP1
SCHEMBL1752645 0.74 KDM1A (0.50) ALDH1A1MEN1KMT2ALMNANPC1
SCHEMBL27722109 0.74 LMNA (0.47) ALDH1A1MEN1KMT2ALMNAMAPT
SCHEMBL6353532 0.74 CHKA (0.45) LMNAMAPK1TDP1
SCHEMBL27915904 0.73 RPS6KA3 (0.39) CHRNB2CHRNA4ALDH1A1ADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2003500402-A 2003-01-07 JP claimed
CN-1361774-A Heterocyclic substituted amino nitrogen heterocycles as central nervous system medicaments ABBOTT INC (US) 2002-07-31 CN claimed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP claimed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO claimed
EP-1347982-A2 SPIRO ISOBENZOFURAN-1,4'-PIPERIDIN]-3-ONES AND 3H-SPIROISOBENZOFURAN-1,4'-PIPERIDINES Neurogen Corporation (US) 2003-10-01 EP disclosed
WO-2002048152-A2 SPIRO[ISOBENZOFURAN-1,4'-PIPERIDIN]-3-ONES AND 3H-SPIROISOBENZOFURAN-1,4'-PIPERIDINES NEUROGEN CORPORATION (US) 2002-06-20 WO disclosed
EP-1178982-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2002-02-13 EP disclosed
WO-2000071534-A1 HETEROCYCLIC SUBSTITUTED AMINOAZACYCLES USEFUL AS CENTRAL NERVOUS SYSTEM AGENTS ABBOTT LABORATORIES (US) 2000-11-30 WO disclosed